Cardiovascular Research Advance Access first published online on December 4, 2007
This version [Corrected Proof] published online on January 22, 2008
Cardiovascular Research, doi:10.1093/cvr/cvm086
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-canonical fibroblast growth factor signalling in angiogenesis
Angiogenesis Research Center and Section of Cardiology, Department of Medicine, and Department of Pharmacology and Toxicology, Dartmouth Medical School, Lebanon, NH 03756, USA
* Corresponding author. Tel: +1 603 650 2631; fax: +1 603 653 0510. E-mail address: masahiro.murakami{at}dartmouth.edu
Whereas fibroblast growth factors (FGFs) classically transmit their signals via high-affinity tyrosine kinase receptors (FGFR1–4), recent evidence strongly implicates non-tyrosine kinase receptors (NTKR) or cell-surface FGFR-interacting proteins as important players in FGF signalling. Although NTKR have lower affinity for FGFs in comparison with cognate tyrosine kinase receptors, because of their high abundance they can effectively bind FGFs and produce unique biological effects independent of FGFRs. A prime example of such NTKR is the syndecan family of plasma membrane proteoglycans and, in particular, syndecan-4, which transmits FGF signalling via a protein kinase C
pathway. Another NTKR, vβ3 integrin, functions as an FGF signalling modulator by binding both FGF2 and FGFR1. Yet another NTKR, neural cell adhesion molecule (NCAM), can serve as an FGFR ligand and assemble an FGFR signalling complex in the absence of FGFs. Furthermore, N-cadherin, which has been reported to associate with FGFR, appears to activate FGFR in both ligand (FGF)-dependent and ligand-independent manners. Finally, gangliosides are implicated as a co-receptor system of FGFs. The biological consequence of non-canonical FGF signalling tends to be less discernable compared to the canonical FGFR activation because of the overlap between these two pathways; nevertheless, non-canonical signalling is important and sometimes essential for cellular functions. Given the diversity of FGF activities through embryonic development to adult physiology, the existence of the non-canonical signalling system may account for the different cellular response to the FGF input in different biological contexts. In this review, we will discuss recent findings related to non-canonical FGF signalling with emphasis on the endothelial biology and angiogenesis.
KEYWORDS Angiogenesis; Cadherins; Growth factors; FGF; NCAM; Signal transduction; Syndecan-4
Time for primary review: 25 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kirschbaum, M. Kriebel, E. U. Kranz, O. Potz, and H. Volkmer Analysis of Non-canonical Fibroblast Growth Factor Receptor 1 (FGFR1) Interaction Reveals Regulatory and Activating Domains of Neurofascin J. Biol. Chem., October 16, 2009; 284(42): 28533 - 28542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Finetti, S. Donnini, A. Giachetti, L. Morbidelli, and M. Ziche Prostaglandin E2 Primes the Angiogenic Switch via a Synergic Interaction With the Fibroblast Growth Factor-2 Pathway Circ. Res., September 25, 2009; 105(7): 657 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Elfenbein, J. M. Rhodes, J. Meller, M. A. Schwartz, M. Matsuda, and M. Simons Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKC{alpha} in a Rac1 activation pathway J. Cell Biol., July 13, 2009; 186(1): 75 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Silvestre, B. I. Levy, and A. Tedgui Mechanisms of angiogenesis and remodelling of the microvasculature Cardiovasc Res, May 1, 2008; 78(2): 201 - 202. [Full Text] [PDF]
|
|